Health

Gene-Driven Adjuvant Therapy for NSCLC Leads to Big Improvement in DFS

TribeNews
By TribeNews Add a Comment
0 Min Read
Gene-Driven Adjuvant Therapy for NSCLC Leads to Big Improvement in DFS

MedPage Today) — CHICAGO — Biomarker-driven adjuvant therapy for intermediate/high-risk non-small cell lung cancer (NSCLC) led to significantly longer disease-free survival (DFS) as compared with observation, a randomized trial showed.
DFS…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app